Compared with non-MASLD controls and obese MASLD patients, lean MASLD patients exhibited higher CD63 levels in serum EVs, while the PLIN3/CD63 ratio was decreased (Figure 6, Table 3). The gene discussed is CD63; the disease is metabolic dysfunction-associated steatotic liver disease.